Delivery Order SPE2DB20D6037-SPE2DB25FTUG3

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,082.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Freestyle Libre 2 sensors. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical products to support the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,447.63 contract is for the delivery of Freestyle Libre 2 sensors, a type of continuous glucose monitoring device, to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order (SPE2DB23FD0ET) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,339.62 contract is for the delivery of Freestyle Libre 2 sensors, which are medical devices used for continuous glucose monitoring. The award is part of a larger indefinite delivery contract (SPE2DB20D6037) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of Freestyle Libre 2 Sensors. The contract has a ceiling value of $1,086.72 and a performance period through January 6, 2023. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,541.39 fixed-price contract is for the supply of Freestyle Libre 2 Sensors, a continuous glucose monitoring device, with a period of performance through August 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order (SPE2DB20D6037|SPE2DB24FC9TP) valued at $1,263.81 for the supply of Freestyle Libre 2 sensors. The contract is a firm fixed-price arrangement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2023. DMS Pharmaceutical Group is an established federal contractor that specializes in providing a wide range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Freestyle Libre 2 sensors. The delivery order is valued at $1,772.76 and has a completion date of July 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 and runs through December 2025. The IDC enables the DLA to...
This is a delivery order from the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,773.29 firm-fixed-price contract is for the delivery of Freestyle Libre 2 Sensors, a medical device used for continuous glucose monitoring. The award has an ultimate completion date of December 16, 2022. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,077.47, is for the delivery of Freestyle Libre 2 continuous glucose monitoring sensors. The contract has a firm fixed price pricing type and a period of performance through October 23, 2024. This order appears to be part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Freestyle Libre 2 Sensors. The $11,964.18 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB25FTUG3
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,228.53, is for the delivery of Freestyle Libre 2 sensors. It is not associated with any set-aside designation.

The contract is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 3/31/25, 9:37 AM